Clinical Trial
-
COVID-19
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
NEW BRUNSWICK, N.J., July 30, 2020 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) (the Company) today announced that its lead vaccine candidate protected against…
Read More » -
Extremities
Mayo TJA Study: Mepivacaine=More Consistent Return of Motor Function Versus Low-Dose Bupivacaine
by Elizabeth Hofheinz, M.P.H., M.Ed. While spinal anesthesia confers benefits when administered during primary total hip arthroplasty (THA) and total…
Read More » -
Biologics
Cerapedics Announces FDA approval of an IDE supplement
WESTMINSTER, Colo., July 22, 2020 — Cerapedics, a private ortho-biologics company, today announced the U.S. Food and Drug Administration (FDA)…
Read More » -
Spine
Empirical Spine Completes Enrollment in Pivotal IDE Clinical Trial Studying LimiFlex in Degenerative Spondylolisthesis
SAN CARLOS, Calif., July 16, 2020 /PRNewswire/ — Empirical Spine, Inc., maker of the LimiFlex Paraspinous Tension Band, today announced completion of…
Read More » -
Extremities
CyMedica Orthopedics Completes e-vive Parent Clinical Trial for Management of Knee Osteoarthritis Pain
SCOTTSDALE, Ariz., June 16, 2020 CyMedica Orthopedics®, the leading combined muscle strengthening therapy and digital health innovator, announced today that…
Read More » -
COVID-19
Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19
June 11, 2020 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and…
Read More » -
COVID-19
Fauci ‘optimistic’ about coronavirus vaccine candidates, says early testing ‘looks quite promising’
June 10, 2020 / By Kayla Rivas | Fox News Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci said…
Read More » -
COVID-19
World Health Organization resumes coronavirus trial on malaria drug hydroxychloroquine after examining safety concerns
June 3, 2020 / Berkeley Lovelace Jr., William Feuer The World Health Organization is resuming its trial of hydroxychloroquine, the malaria…
Read More » -
COVID-19
Russians claim to have an effective treatment for the coronavirus, which hospitals will start using this month
June 1, 2020 / Holly Ellyatt Russia has approved an anti-influenza drug, Aviifavir, to treat Covid-19 and will start delivering…
Read More » -
Biologics
Cerapedics Announces Results from Clinical Trial of i-FACTOR® Peptide Enhanced Bone Graft in Lumbar Fusion Surgery
WESTMINSTER, Colo., May 19, 2020 /PRNewswire/ — Cerapedics, a private ortho-biologics company, today announced that results from a clinical trial evaluating i-FACTOR Peptide…
Read More » -
COVID-19
Early results from Moderna coronavirus vaccine trial show participants developed antibodies against the virus
May 18, 2020 / By Elizabeth Cohen, Senior Medical Correspondent (CNN) – Study subjects who received Moderna’s Covid-19 vaccine had positive…
Read More » -
COVID-19
Coronavirus vaccine: This week’s updates from Oxford and the NIH
May 15, 2020 / By Erika Edwards The race to develop a COVID-19 vaccine is on, as scientists work as quickly…
Read More » -
COVID-19
Fueled By $500 Million In Federal Cash, Moderna Races To Make A Billion Doses Of An Unproven Cure
May 8, 2020 / Leah Rosenbaum, Forbes Staff The company’s billionaire CEO has secured huge grants on the promise of…
Read More » -
COVID-19
Pfizer, BioNTech begin coronavirus vaccine trial in humans
May 5, 2020 / By Kayla Rivas | Fox News The first doses of a coronavirus vaccine have been injected into human patients, Pfizer…
Read More » -
COVID-19
FDA will reportedly authorize use of remdesivir for Covid-19 after trial shows ‘positive effect’ on recovery time
April 30, 2020 / By Maggie Fox, Jamie Gumbrecht, Holly Yan and Betsy Klein, CNN (CNN) – Researchers released some good news about a possible…
Read More »